Rankings
▼
Calendar
RAPP Q3 2025 Earnings — Rapport Therapeutics, Inc. Common Stock Revenue & Financial Results | Market Cap Arena
RAPP
Rapport Therapeutics, Inc. Common Stock
$1B
Q3 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$30M
Net Income
-$27M
EPS (Diluted)
$-0.71
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$17M
Free Cash Flow
-$18M
Stock-Based Comp.
$5M
Balance Sheet
Total Assets
$535M
Total Liabilities
$24M
Stockholders' Equity
$512M
Cash & Equivalents
$251M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
$0
—
Operating Income
-$30M
-$22M
-38.6%
Net Income
-$27M
-$18M
-53.5%
← FY 2025
All Quarters
Q4 2025 →